Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TFFP
DateTimeSourceHeadlineSymbolCompany
05/17/20243:07PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
05/17/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
05/14/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
05/14/20243:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
05/06/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
12/19/20235:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
12/15/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
12/12/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
12/08/20233:52PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
12/08/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
12/04/20234:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
12/04/20234:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
12/04/20234:25PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
11/22/20234:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
11/21/20233:41PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
11/14/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
10/04/20233:10PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
10/04/20233:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
10/04/20233:07PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
09/22/20233:16PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
09/18/20234:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
09/18/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
08/17/20233:01PMGlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
08/16/20233:43PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
08/15/20237:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
08/15/20237:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
08/15/20235:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
08/15/20235:00AMGlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
08/14/20233:12PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
08/14/20233:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TFFP

Your Recent History

Delayed Upgrade Clock